To explore the potential mechanism by which SLC12A5 contributes to the progression and therapeutic resistance of prostate cancer, a BioGRID (biomedical interaction repository with data compiled through comprehensive curation efforts) analysis was used to seek the SLC12A5 interacting proteins. The gene discussed is SLC12A5; the disease is prostate carcinoma.